期刊文献+

Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China 被引量:1

下载PDF
导出
摘要 AIM: To evaluate the effect of a 6 and 12 mo lifestyle modification intervention in nonalcoholic fatty liver diseases (NAFLD) in Chengyang District of Qingdao. METHODS: Participants with NAFLD who had resided in Chengyang District for more than 5 years were enrolled in this study. After the 6 and 12 mo lifestyle modification intervention based on physical activity, nutrition and behavior therapy, parameters such as body weight, body mass index (BMI), waist circumference, serum alanine aminotransferase (ALT), aspartate aminotransferase values, serum cholesterol, triglycerides, fasting glucose, fasting insulin and visceral fat area (VFA), the liver-spleen ratio and the homeostasis model assessment of insulin resistance (HOMA-IR) were evaluated and compared between participants with and without the intervention. RESULTS: Seven hundred and twenty-four participants were assigned to the lifestyle intervention group (LS) and 363 participants were assigned to the control group (CON). After the intervention, body weights in the LS group were significantly decreased compared to those in the CON group at 6 mo (11.59% ± 4.7% vs 0.4% ± 0.2%, P = 0.001) and at 12 mo (12.73% ± 5.6% vs 0.9% ± 0.3%, P = 0.001). Compared with the CON group, BMI was more decreased in the LS group after 6 and 12 mo (P = 0.043 and P = 0.032). Waist circumference was more reduced in the LS group than in CON (P = 0.031 and P = 0.017). After the 6 and 12 mo intervention, ALT decreased significantly in the LS group (P = 0.003 and P = 0.002). After 6 and 12 mo, the metabolic syndrome rate had decreased more in the LS group compared with the CON group (P = 0.026 and P = 0.017). After 12 mo, the HOMA-IR score decreased more obviously in the LS group (P = 0.041); this result also appeared in the VFA after 12 mo in the LS group (P = 0.035). CONCLUSION: Lifestyle intervention was effective in improving NAFLD in both 6 and 12 mo interventions. This intervention offered a practical approach for treating a large number of NAFLD patients in the Chengyang District of Qingdao. AIM: To evaluate the effect of a 6 and 12 mo lifestyle modification intervention in nonalcoholic fatty liver diseases (NAFLD) in Chengyang District of Qingdao. METHODS: Participants with NAFLD who had resided in Chengyang District for more than 5 years were enrolled in this study. After the 6 and 12 mo lifestyle modification intervention based on physical activity, nutrition and behavior therapy, parameters such as body weight, body mass index (BMI), waist circumference, serum alanine aminotransferase (ALT), aspartate aminotransferase values, serum cholesterol, triglycerides, fasting glucose, fasting insulin and visceral fat area (VFA), the liver-spleen ratio and the homeostasis model assessment of insulin resistance (HOMA-IR) were evaluated and compared between participants with and without the intervention. RESULTS: Seven hundred and twenty-four participants were assigned to the lifestyle intervention group (LS) and 363 participants were assigned to the control group (CON). After the intervention, body weights in the LS group were significantly decreased compared to those in the CON group at 6 mo (11.59% ± 4.7% vs 0.4% ± 0.2%, P = 0.001) and at 12 mo (12.73% ± 5.6% vs 0.9% ± 0.3%, P = 0.001). Compared with the CON group, BMI was more decreased in the LS group after 6 and 12 mo (P = 0.043 and P = 0.032). Waist circumference was more reduced in the LS group than in CON (P = 0.031 and P = 0.017). After the 6 and 12 mo intervention, ALT decreased significantly in the LS group (P = 0.003 and P = 0.002). After 6 and 12 mo, the metabolic syndrome rate had decreased more in the LS group compared with the CON group (P = 0.026 and P = 0.017). After 12 mo, the HOMA-IR score decreased more obviously in the LS group (P = 0.041); this result also appeared in the VFA after 12 mo in the LS group (P = 0.035). CONCLUSION: Lifestyle intervention was effective in improving NAFLD in both 6 and 12 mo interventions. This intervention offered a practical approach for treating a large number of NAFLD patients in the Chengyang District of Qingdao.
出处 《World Journal of Hepatology》 CAS 2012年第7期224-230,共7页 世界肝病学杂志(英文版)(电子版)
关键词 Non-alcoholic FATTY liver disease LIFESTYLE INTERVENTION OBESE Non-alcoholic fatty liver disease Lifestyle intervention Obese
  • 相关文献

参考文献20

  • 1田小草,逄增昌,汪韶洁,程亮,宁峰,乔青.青岛市35岁以上人群腰围与血压、血脂、血糖的关系分析[J].预防医学论坛,2011,17(2):119-121. 被引量:4
  • 2逄增昌,陈晓荣,汪韶洁,石学香,苑妹.青岛市居民膳食结构和营养状况调查[J].中国公共卫生,2006,22(1):91-92. 被引量:20
  • 3Valerio Nobili,Arun J. Sanyal.Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal[J]. Journal of Gastroenterology . 2012 (1)
  • 4Nakagaichi M,Tanaka K.Development of a 12-min treadmill walk test at a self-selected pace for the evaluation of cardiorespiratory fitness in adult men. Applied Human Science Journal of Physiological Anthropology . 1998
  • 5Astrand PO,Rodahl K.Applied sports physiology. Textbook of work physiology hysiological bases of exercise . 1986
  • 6International Diabetes Federation.The IDF consensus worldwide definition of the metabolic syndrome. http: //www.idf.org/webdata/docs/MetS_def_update2006.pdf . 2009
  • 7Kubey R,Csikszentmihalyi M.Television addiction is nomere metaphor. Scientific American . 2002
  • 8Sookoian S,irola CJ.DNA methylation and hepatic insulin resistance and steatosis. Current Opinion in Clinical Nutrition and Metabolic Care . 2012
  • 9Gossard AA,Lindor KD.Current therapies for nonalcoholic fatty liver disease. Drugs of Today . 2011
  • 10Malavolti M,Battistini NC,Miglioli L,Bagni I,Borelli L,Marino M,Scaglioni F,Bellentani S.Influence of lifestyle habits, nutritional status and insulin resistance in NAFLD. Front Biosci (Elite Ed) . 2012

二级参考文献9

  • 1Dobbelsteyn CJ, Joffres MR, Maclcan OR, et al. A comparative evaluat-oon ot waist circumference,waist to hipratio and body mass index as indicators of cardiovascular risk factors. The canadian heart health surveys[J]. Int J Obes Relat Metab Disord,2001,25(5) :652-661.
  • 2Kissebah AH, Krakower GR. Regional adiposity and mortality[J]. Physiol Rev,1994,74(4) :761-811.
  • 3Despres JP,Lemieux I,Prud'homme D, et al . Treatment of obesity: need to focus on high risk abdominally obese patients[J]. BMJ, 2001 ,.322(7 288) :716-720.
  • 4Pouliot MC, Despres JP, Lemieux S, et al . Waist circumference andabdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovas cular risk in men and women[J]. AmJ Cardiol, 1994,73 (7):,460-468.
  • 5Guaik TJ, Mangalat D, Korbut R. Adipocytokines-novel link between inflammation and vascular function? [J]. Physiol Pharmac, 2006,57 (4) :505-528.
  • 6胡世红,贾卫鸿,韦春凌.成年人腰围与血压、血脂及血糖关系[J].中国慢性病预防与控制,2007,15(5):459-461. 被引量:17
  • 7中国居民膳食指南及平衡膳食宝塔[J].营养学报,1998,20(4):387-397. 被引量:190
  • 8翟凤英,马林茂,于文涛,郭旭光,金水高,葛可佑.24小时个人膳食询问法在中国营养调查中的应用[J].卫生研究,1996,25(S1):51-56. 被引量:16
  • 9贾伟平,陆俊茜,项坤三,包玉倩,陆惠娟,陈蕾.简易体脂参数估测腹内型肥胖的可靠性评价[J].中华流行病学杂志,2002,23(1):20-23. 被引量:131

共引文献28

同被引文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部